
Alexion Pharmaceuticals
RepVue Score
Alexion Pharmaceuticals
To ensure data accuracy, this profile must meet the following requirements to be ranked and receive a RepVue score and industry category rankings.
Performance Category Ratings
See how employees rated Alexion Pharmaceuticals in RepVue’s key performance categories.
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to...More
Percent that Attain Quota?
Pharma and Biotech Industry Average
47%Global Average
44%Approximately 46% of reps at Alexion Pharmaceuticals meet or exceed their annual quota based on ratings submitted in the past year.
Employee Ratings
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to...More
Percent that Attain Quota?
Pharma and Biotech Industry Average
47%Global Average
44%Approximately 46% of reps at Alexion Pharmaceuticals meet or exceed their annual quota based on ratings submitted in the past year.